Efficacy of Siponimod in secondary progressive multiple sclerosis patients with active disease: the EXPAND study subgroup analysis

被引：0
|
作者：
Gold, R. [1 ]
Kappos, L. [2 ,3 ,4 ,5 ,6 ]
Bar-Or, A. [7 ]
Vermersch, P. [8 ]
Giovannoni, G. [9 ]
Fox, R. [10 ]
Rouyrre, N. [11 ]
Karlsson, G. [11 ]
Cree, B. A. C. [12 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
[2] Univ Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland
[3] Univ Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland
[4] Univ Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland
[5] Univ Hosp, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland
[6] Univ Basel, Basel, Switzerland
[7] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada
[8] Univ Lille, Dept Neurol, Lille, France
[9] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[10] Cleveland Clin, Neurol Inst, Mellen Ctr Treatment & Res Multiple Sclerosis, Cleveland, OH 44106 USA
[11] Novartis Pharma AG, Basel, Switzerland
[12] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P750
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [1] The EXPAND study results: Efficacy of siponimod in secondary progressive multiple sclerosis
    Vermersch, P.
    Bar-Or, A.
    Cree, B.
    Fox, R.
    Giovannoni, G.
    Gold, R.
    Arnould, S.
    Wallstroem, E.
    Sidorenko, T.
    Wolf, C.
    Dahlke, F.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 44 - 44
  • [2] Effect of Siponimod on Cognition in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Phase 3 EXPAND Study Subgroup Analysis
    Benedict, Ralph
    Fox, Robert
    Tomic, Davorka
    Cree, Bruce
    Vermersch, Patrick
    Giovannoni, Gavin
    Bar-Or, Amit
    Gold, Ralf
    Ritter, Shannon
    Karlsson, Goeril
    Wolf, Christian
    Kappos, Ludwig
    [J]. NEUROLOGY, 2019, 92 (15)
  • [3] Analyses of the effect of baseline age on the efficacy and safety of siponimod in patients with active secondary progressive multiple sclerosis from the EXPAND study
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Cree, B. Ac
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 551 - 552
  • [4] Safety and efficacy of siponimod in patients with active secondary progressive multiple sclerosis identifying as Hispanic from the phase 3 EXPAND study
    Cohan, S.
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Coyle, P. K.
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 590 - 591
  • [5] Siponimod Improves Cognitive Processing Speed in Patients with Secondary Progressive Multiple Sclerosis: EXPAND Subgroup Analyses
    Benedict, R.
    Tomic, D.
    Fox, R.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-Or, A.
    Gold, R.
    Ritter, Sh.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP20 - NP21
  • [6] Siponimod improves cognitive processing speed in patients with secondary progressive multiple sclerosis: EXPAND subgroup analyses
    Benedict, R.
    Fox, R.
    Tomic, D.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Ritter, S.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 868 - 868
  • [7] Siponimod Reduces Grey Matter Atrophy in Patients with Secondary Progressive Multiple Sclerosis: Subgroup Analyses from the EXPAND Study
    Fox, Robert
    Arnold, Douglas
    Giovannoni, Gavin
    Cree, Bruce
    Vermersch, Patrick
    Bar-Or, Amit
    Gold, Ralf
    Benedict, Ralph
    Meier, Daniela Piani
    Arnould, Sophie
    Ritter, Shannon
    Dahlke, Frank
    Karlsson, Goeril
    Kappos, Ludwig
    [J]. NEUROLOGY, 2020, 94 (15)
  • [8] Effect of Siponimod on Grey Matter Atrophy in Patients with Secondary Progressive Multiple Sclerosis: Subgroup Analyses from the EXPAND Study
    Vennersch, P.
    Fox, R. J.
    Arnold, D. L.
    Giovannoni, G.
    Cree, B. A. C.
    Bar-Or, A.
    Golds, R.
    Benedict, R. H. B.
    Piaui-Meier, D.
    Arnould, S.
    Ritter, S.
    Dahlke, F.
    Karlsson, G.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 478 - 478
  • [9] The EXPAND study results: Safety and tolerability of siponimod in patients with secondary progressive multiple sclerosis
    Giovannoni, G.
    Bar-or, A.
    Cree, B.
    Fox, R.
    Gold, R.
    Vermersch, P.
    Pohlmann, H.
    Wallstrom, E.
    Wolf, C.
    Dahlke, F.
    Sidorenko, T.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 495 - 495
  • [10] Siponimod for active secondary progressive multiple sclerosis
    Gaber, Tarek
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5
12345